Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06172985
Other study ID # CT-091-2022
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date May 9, 2023
Est. completion date February 29, 2024

Study information

Verified date August 2023
Source Keya Medical
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this clinical trail is to evaluate the effectiveness and accuracy of the CCTA image assisted triage software(DeepVessel® Cardisight, Keya Medical.) for the triage of patients with suspected coronary artery disease.


Description:

The CCTA images collected by each center within a certain period of time would be screened, desensitized, and then evaluated by the software and independent expert group respectively, to evaluate the effectiveness and accuracy of the coronary CT angiography image stenosis assisted triage software developed by Koyal Medical Technology Co. Experiment group: Evaluated by the software Independent expert group: Evaluated by experts (≥5 years of CCTA experience required)


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1093
Est. completion date February 29, 2024
Est. primary completion date June 8, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. CCTA images acquired by CT detectors need to meet the following requirements: - Check Modal = CT - Number of detector rows = 64 rows - Layer thickness =1mm - Layer spacing =1mm - Pixel pitch = 0.5mm - Ball tube voltage = 70kV - Number of layers = 100 layers 2. CCTA image quality score = 3 (5-point Likert scale). Exclusion Criteria: 1. Severe coronary artery calcification, which in the judgment of readers affects the stenosis adjudicator; 2. Previous percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG); 3. Congenital anomalies of coronary artery origin or other malformations; 4. Coronary artery occlusive lesions; 5. Implantation of the pacemaker, internal defibrillator electrode, or prosthetic heart valve.

Study Design


Intervention

Other:
No intervention
Due to observational study

Locations

Country Name City State
China Fuwai Hospital, Chinese Academy of Medical Sciences Beijing Beijing
China The Pearl River Hospital of Southern Medical University Guangzhou Guangdong
China Huanggang Central Hospital Huanggang Hubei
China The First Affiliated Hospital of Hebei Medical University Shijiazhuang Hebei
China Affiliated Hospital of Zunyi Medical University Zunyi Guizhou

Sponsors (1)

Lead Sponsor Collaborator
Keya Medical

Country where clinical trial is conducted

China, 

References & Publications (5)

Choi AD, Marques H, Kumar V, Griffin WF, Rahban H, Karlsberg RP, Zeman RK, Katz RJ, Earls JP. CT Evaluation by Artificial Intelligence for Atherosclerosis, Stenosis and Vascular Morphology (CLARIFY): A Multi-center, international study. J Cardiovasc Compu — View Citation

Lucke C, Foldyna B, Andres C, Boehmer-Lasthaus S, Grothoff M, Nitzsche S, Gutberlet M, Lehmkuhl L. Post-processing in cardiovascular computed tomography: performance of a client server solution versus a stand-alone solution. Rofo. 2014 Dec;186(12):1111-21 — View Citation

Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA, Nieman K, van Werkhoven JM, Pundziute G, Weustink AC, de Vos AM, Pugliese F, Rensing B, Jukema JW, Bax JJ, Prokop M, Doevendans PA, Hunink MG, Krestin GP, de Feyter PJ. Diagnostic ac — View Citation

Meyer M, Schoepf UJ, Fink C, Goldenberg R, Apfaltrer P, Gruettner J, Vajcs D, Schoenberg SO, Henzler T. Diagnostic performance evaluation of a computer-aided simple triage system for coronary CT angiography in patients with intermediate risk for acute cor — View Citation

Paul JF, Rohnean A, Giroussens H, Pressat-Laffouilhere T, Wong T. Evaluation of a deep learning model on coronary CT angiography for automatic stenosis detection. Diagn Interv Imaging. 2022 Jun;103(6):316-323. doi: 10.1016/j.diii.2022.01.004. Epub 2022 Ja — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Device Defects In the course of clinical trials, there are unreasonable risks that may endanger human health and life safety under normal use of medical devices, such as label errors, quality problems, and frequent failures October 13,2022 to March 1,2023
Primary Sensitivity and specificity of experiment group in triage for patients with suspected coronary artery disease Based on the results of the independent expert group, uses stenosis degree=50% as the boundary for triage indication on a per-patient basis. October 13,2022 to March 1,2023
Secondary Diagnostic time Independent expert group: recording the sum of image post-processing time (T1) and the time to produce the results (T2); Experimental group: recording the time from image post-processing to outputting results; Calculate the difference between the two groups. October 13,2022 to March 1,2023
Secondary Patient as research unit Evaluation criteria were established based on the results of the independent expert group to evaluate the total conformity rate, KAPPA value, positive predictive value (PPV) and negative predictive value (NPV) of triage tips for patients with suspected coronary heart disease in the experimental group. October 13,2022 to March 1,2023
Secondary Blood vessels were used as the research unit Evaluation criteria were established based on the results of the independent expert group to evaluate the total conformity rate, KAPPA value, positive predictive value (PPV) and negative predictive value (NPV) of triage tips for patients with suspected coronary heart disease in the experimental group. October 13,2022 to March 1,2023
Secondary The vascular segment was used as the research unit Evaluation criteria were established based on the results of the independent expert group to evaluate the total conformity rate, KAPPA value, positive predictive value (PPV) and negative predictive value (NPV) of triage tips for patients with suspected coronary heart disease in the experimental group. October 13,2022 to March 1,2023
Secondary Gender stratified statistics, respectively, with patients and blood vessels as research units Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease October 13,2022 to March 1,2023
Secondary Manufacturer stratified statistics, respectively, with patients and blood vessels as research units Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease October 13,2022 to March 1,2023
Secondary Row number stratified statistics, respectively, with patients and blood vessels as research units Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease October 13,2022 to March 1,2023
Secondary The stratified statistics of tube voltage were conducted with patients and blood vessels as research units Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease October 13,2022 to March 1,2023
Secondary Layer thickness stratified statistics, patients and blood vessels were used as research units Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease October 13,2022 to March 1,2023
Secondary The patients and blood vessels were selected as the research units Evaluation criteria were established based on the results of the independent expert group to evaluate the sensitivity and specificity of the trial group to the triage hints of suspected patients with coronary heart disease October 13,2022 to March 1,2023
Secondary Post-processing image quality evaluation Calculate the percentage of post-processing images with the image quality score of 2 or above in the total post-processing images, and the difference between the independent expert group and experimental group. October 13,2022 to March 1,2023
Secondary Software performance evaluation From the function of use, ease of operation, stability to evaluate, divided into satisfactory, general, unsatisfactory three levels. October 13,2022 to March 1,2023
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Completed NCT05088291 - Application of a New X-ray Protective Device in Coronary Interventional Therapy
Completed NCT03076801 - Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease? N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Not yet recruiting NCT04995159 - Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System N/A
Recruiting NCT02967718 - Innovation Research of Differentiation and Treatment Methods Based on CHD Phlegm and Blood Stasis Syndrome N/A
Completed NCT02888652 - Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
Completed NCT02163044 - The Hellenic Postprandial Lipemia Study (HPLS)
Terminated NCT02045134 - Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery N/A
Active, not recruiting NCT02244853 - Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease N/A
Completed NCT01826552 - Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent Phase 4
Completed NCT01920009 - Impact of Motivational Interviews Within Pharmacy Care Upon Adherence to Cardiovascular Medicines N/A
Completed NCT02440893 - Understanding the Effect of Metformin on Corus CAD (or ASGES)
Terminated NCT01906957 - Cognition and Exercise Training N/A
Completed NCT02753829 - Home-based Cardiovascular Rehabilitation, Maintenance Phase, in Subjects With Coronary Artery Disease N/A
Recruiting NCT01689688 - Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography N/A
Completed NCT01779401 - Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients N/A
Recruiting NCT01462799 - COR-PRIM: Problem-based Learning (PBL) After Coronary Heart Disease (CHD) - Long-term Evaluation in Primary Care of Self-care N/A
Recruiting NCT01456364 - Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing Phase 4
Completed NCT01486030 - Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test